Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Machine Learning Approach to Alzheimer's Detection From Continuous Blood Glucose Monitoring Data

NCT04614376 is registered in ClinicalTrials.gov with Bio Conscious Technologies Inc. as lead sponsor.

NCT NCT04614376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04614376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Machine Learning Approach to Alzheimer's Detection From Continuous Blood Glucose Monitoring Data
Lead sponsor
Bio Conscious Technologies Inc.
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2020
Completion date
March 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment